| USP订购编号 |
美国药典，USP分析标准品，英文名称，规格 |
CAS编号查询 |
UN编号对照 |
| USP-1225204 |
Dopamine Hydrochloride (200 mg) |
62-31-7 |
UN3077 |
| USP-1225215 |
Dopamine Related Compound A (30 mg) (5-(2-Aminoethyl)-2-methoxyphenol) |
3213-30-7 |
|
| 2922299000 |
|
|
|
| USP-1225226 |
Dopamine Related Compound B (30 mg) (4-(2-Aminoethyl)-2-methoxyphenol hydrochloride) |
1477-68-5 |
|
| 2922299000 |
|
|
|
| USP-1225281 |
Dorzolamide Hydrochloride (200 mg) |
130693-82-2 |
|
| 2935904000 |
|
|
|
| USP-1225292 |
Dorzolamide Hydrochloride Related Compound A (20 mg) ((4R,6R)-4-(ethylamino)-5,6-dihydro-6-methyl-4H-thieno[2,3-b]thiopyran-2-sulfonamide-7,7-dioxide, monohydrochloride) |
122028-36-8 |
|
| 2935909550 |
|
|
|
| USP-1225306 |
Dorzolamide Related Compound D (30 mg) ((4S,6S)-4-Amino-6-methyl-5,6-dihydro-4H-thieno[2,3-b]thiopyran-2-sulfonamide 7,7-dioxide hydrochloride) |
164455-27-0 |
|
| 2935909550 |
|
|
|
| USP-1225317 |
Dorzolamide Related Compound B (15 mg) ((4RS,6SR)-4-(Ethylamino)-6-methyl-5,6-dihydro-4H-thieno[2,3-b]thiopyran-2-sulfonamide 7,7-dioxide hydrochloride) |
120279-37-0 |
|
| 2935909550 |
|
|
|
| USP-1225419 |
Doxazosin Mesylate (200 mg) |
77883-43-3 |
|
| 2934990005 |
|
|
|
| USP-1225420 |
Doxazosin Related Compound A (20 mg) (N-1,4-Benzodioxane-2-carbonyl piperazine hydrochloride) |
70918-74-0 |
UN2811 |
| USP-1225441 |
Doxazosin Related Compound B (20 mg) (6,7-dimethoxyquinazoline-2,4-dione) |
28888-44-0 |
|
| 2933997500 |
|
|
|
| USP-1225452 |
Doxazosin Related Compound C (20 mg) (2-chloro-4-amino-6,7-dimethoxyquinazoline) |
23680-84-4 |
|
| 2933599550 |
|
|
|
| USP-1225463 |
Doxazosin Related Compound D (20 mg) (1,4-benzodioxane-2-carboxylic acid) |
3663-80-7 |
|
| 2932996560 |
|
|
|
| USP-1225474 |
Doxazosin Related Compound E (20 mg) (2,4-dichloro-6,7-dimethoxyquinazoline) |
27631-29-4 |
|
| 2933599550 |
|
|
|
| USP-1225485 |
Doxazosin Related Compound F (15 mg) (N,N’-bis(1,4-benzodioxane-2-carbonyl)piperazine) |
617677-53-9 |
|
| 2934990005 |
|
|
|
| USP-1225496 |
Doxazosin Related Compound G (15 mg) (4-Amino-6,7-dimethoxyquinazolin-2(1H)-one hydrochloride) (需冷链运输) |
134749-43-2 |
|
| 2933599550 |
|
|
|
| USP-1225500 |
Doxepin Hydrochloride (500 mg) |
1229-29-4 |
UN2811 |
| USP-1225511 |
Doxepin Related Compound A (50 mg) (dibenzo[b,e]oxepin-11(6H)-one) |
4504-87-4 |
|
| 2932996560 |
|
|
|
| USP-1225522 |
Doxepin Related Compound B (50 mg) ((11RS)-11-[3-(dimethylamino)propyl]-6,11-dihydrodibenzo[b,e]oxepin-11-ol) |
4504-88-5 |
|
| 2932996560 |
|
|
|
| USP-1225533 |
Doxepin Related Compound C (25 mg) ((E,Z)-3-(Dibenzo[b,e]oxepin-11(6H)-ylidene)-N-methylpropan-1-amine hydrochloride) |
2887-91-4 |
|
| 2932996560 |
|
|
|
| USP-1225703 |
Doxorubicin Hydrochloride (50 mg) |
25316-40-9 |
|
| 2941906000 |
|
|
|
| USP-1225758 |
Doxorubicinone (25 mg) ((8S,10S)-6,8,10,11-Tetrahydroxy-8-(hydroxyacetyl)-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione) |
24385-10-2 |
|
| 2914500000 |
|
|
|
| USP-1225984 |
Doxycycline Monohydrate (100 mg) |
17086-28-1 |
|
| 2941300000 |
|
|
|
| USP-1226003 |
Doxycycline Hyclate (200 mg) |
24390-14-5 |
|
| 2941300000 |
|
|
|
| USP-1226014 |
Doxycycline Related Compound A (10 mg) ((4S,4aR,5S,5aR,6S,12aS)-4-(Dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide, monohydrochloride) |
41411-66-9 |
|
| 2941300000 |
|
|
|
| USP-1227006 |
Doxylamine Succinate (300 mg) |
562-10-7 |
|
| 2933399095 |
|
|
|
| USP-1228009 |
Drometrizole (25 mg) (2-(2H-Benzotriazol-2-yl)-p-cresol) |
2440-22-4 |
|
| 2933997500 |
|
|
|
| USP-1228010 |
Drometrizole Trisiloxane (200 mg) |
155633-54-8 |
|
| 2933997500 |
|
|
|
| USP-1228029 |
Drometrizole Trisiloxane Related Compound A (25 mg) (2-(2H-Benzotriazol-2-yl)-6-(isobuten-1-yl)-p-cresol) |
2170-37-8 |
|
| 2933997500 |
|
|
|
| USP-1228031 |
Drometrizole Trisiloxane Related Compound B (25 mg) (2-(2H-Benzotriazol-2-yl)-6-(isobuten-3-yl)-p-cresol) |
98809-58-6 |
|
| 2933997500 |
|
|
|
| USP-1228053 |
Drometrizole Trisiloxane Related Compound D (25 mg) (2-(2H-Benzotriazol-2-yl)-6-isobutyl-p-cresol) |
N/A |
|
| 2933997500 |
|
|
|
| USP-1228530 |
Dronedarone Hydrochloride (125 mg) |
141625-93-6 |
UN3077 |
| USP-1228541 |
Dronedarone Related Compound A (25 mg) (N-{2-Butyl-3-[4-(3-butylaminopropoxy)benzoyl]benzofuran-5-yl}methanesulfonamide, hydrochloride) |
197431-02-0 |
|
| 2932996560 |
|
|
|
| USP-1228552 |
Dronedarone Related Compound B (20 mg) ((5-Amino-2-butylbenzofuran-3-yl){4-[3-(dibutylamino)propoxy]phenyl}methanone, dihydrochloride) |
1309476-91-2 |
|
| 2932996560 |
|
|
|
| USP-1228563 |
Dronedarone Related Compound C (20 mg) ((5-Amino-2-butylbenzofuran-3-yl)(4-hydroxyphenyl)methanone) |
1278585-68-4 |
|
| 2932996560 |
|
|
|
| USP-1228574 |
Dronedarone Related Compound D (20 mg) ((2-Butyl-5-nitrobenzofuran-3-yl)(4-hydroxyphenyl)methanone) |
141645-16-1 |
|
| 2932996560 |
|
|
|
| USP-1229001 |
Droperidol (250 mg) |
548-73-2 |
|
| 2933995800 |
|
|
|
| USP-1229409 |
Drospirenone (200 mg) |
67392-87-4 |
|
| 2937230000 |
|
|
|
| USP-1229410 |
Drospirenone Related Compound A (15 mg) (17-Hydroxy-6beta,7beta:15beta,16beta-dimethylene-3-oxo-17beta-pregn-4-ene-21-carboxylic acid, gamma-lactone) |
90457-65-1 |
|
| 2932206000 |
|
|
|
| USP-1229817 |
Duloxetine Hydrochloride (100 mg) |
136434-34-9 |
UN2811 |
| USP-1229828 |
Duloxetine Related Compound A (10 mg) ((R)-N-Methyl-3-(naphthalen-1-yloxy)-3-(thiophen-2-yl)propan-1-amine hydrochloride) |
910138-96-4 |
UN2811 |
| USP-1229872 |
Duloxetine Related Compound F (10 mg) ((S)-N-Methyl-3-(naphthalen-1-yloxy)-3-(thiophen-3-yl)propan-1-amine hydrochloride) |
N/A |
|
| 2934990005 |
|
|
|
| USP-1229922 |
Dutasteride (200 mg) |
164656-23-9 |
|
| 2937290000 |
|
|
|
| USP-1229931 |
Dutasteride Resolution Mixture (20 mg) |
N/A |
|
| 2937290000 |
|
|
|
| USP-1230000 |
Dyclonine Hydrochloride (200 mg) |
536-43-6 |
UN2811 |
| USP-1231003 |
Dydrogesterone (200 mg) |
152-62-5 |
UN3077 |
| USP-1231502 |
Dyphylline (200 mg) |
479-18-5 |
|
| 2939590000 |
|
|
|
| USP-1231604 |
Ecamsule Triethanolamine (200 mg) |
92841-53-7 |
|
| 2914710000 |
|
|
|
| USP-1231615 |
Ecamsule Related Compound A (50 mg) (1,4-Phenylenedimethanol) |
589-29-7 |
|
| 2906290000 |
|
|
|
| USP-1241619 |
Erlotinib Related Compound A (25 mg) (4-(3-{[6,7-Bis(2-methoxyethoxy) quinazolin-4-yl]amino}phenyl)-2-methyl-3-butyn-2-ol hydrochloride) |
299912-59-7 |
|
| 2933599550 |
|
|
|
| USP-1241823 |
Erythorbic Acid (50 mg) |
89-65-6 |
|
| 2932206000 |
|
|
|
| USP-1241903 |
Erythritol (200 mg) |
149-32-6 |
|
| 2905490000 |
|
|
|
| USP-1242000 |
Erythromycin (250 mg) |
114-07-8 |
UN3077 |
| USP-1242010 |
Erythromycin B (100 mg) |
527-75-3 |
|
| 2941500000 |
|
|
|
| USP-1242021 |
Erythromycin C (50 mg) |
1675-02-1 |
|
| 2941500000 |
|
|
|
| USP-1242032 |
Erythromycin Related Compound N (50 mg) (N-Demethylerythromycin A) |
992-62-1 |
|
| 2932206000 |
|
|
|
| USP-1243002 |
Erythromycin Estolate (200 mg) |
3521-62-8 |
|
| 2941500000 |
|
|
|
| USP-1245008 |
Erythromycin Ethylsuccinate (200 mg) |
1264-62-6 |
|
| 2941500000 |
|
|
|
| USP-1247003 |
Erythromycin Lactobionate (200 mg) |
3847-29-8 |
|
| 2941500000 |
|
|
|
| USP-1248006 |
Erythromycin Stearate (200 mg) |
643-22-1 |
|
| 2941500000 |
|
|
|
| USP-1248218 |
Erythropoietin (100 ug) |
113427-24-0 |
|
| 2937190000 |
|
|
|
| USP-1249202 |
Escin (350 mg) |
11072-93-8 |
|
| 2938900000 |
|
|
|
| USP-1249406 |
Escitalopram Oxalate (200 mg) |
219861-08-2 |
|
| 2932996560 |
|
|
|
| USP-1249417 |
Escitalopram Related Compound A (10 mg) ((S)-4-[4-dimethylamino-1-(4-fluoropheny)-1-hydroxy-1-butyl]-3-hydroxymethylbenzonitrile hemi(+)-di-toluoyltartrate) |
128173-53-5 |
|
| 2926900005 |
|
|
|
| USP-1249701 |
Esmolol Hydrochloride (100 mg) |
81161-17-3 |
|
| 2922190900 |
|
|
|
| USP-1249789 |
Esomeprazole Magnesium (100 mg) |
217087-09-7 |
|
| 2933399095 |
|
|
|
| USP-1249790 |
Esomeprazole Sodium (200 mg) |
161796-78-7 |
|
| 2933399095 |
|
|
|
| USP-1249803 |
Esomeprazole Strontium (20 mg) |
934714-36-0 |
|
| 2933399095 |
|
|
|
| USP-1249916 |
Estazolam Related Compound A (10 mg) (5-Chloro-2-(3-chloromethyl-4H-1,2,4-triazol-4-yl)-benzophenone) |
37945-06-5 |
|
| 2933999552 |
|
|
|
| USP-1250008 |
Estradiol (500 mg) |
35380-71-3 |
|
| 2937230000 |
|
|
|
| USP-1250020 |
Estradiol Related Compound B (10 mg) (1,3,5(10),6-estratetraen-3,17beta-diol) |
7291-41-0 |
|
| 2937230000 |
|
|
|
| USP-1250041 |
Estradiol Related Compound C (15 mg) (1,3,5(10)-estratrien-3,17beta-diol-6-one) |
571-92-6 |
|
| 2937230000 |
|
|
|
| USP-1251000 |
Estradiol Benzoate (250 mg) |
50-50-0 |
|
| 2937230000 |
|
|
|
| USP-1269174 |
Famciclovir Related Compound A (20 mg) (2-[2-(2-Amino-9H-purin-9-yl)ethyl]propane-1,3-diol] hydrochloride) |
246021-75-0; 104227-86-3 (base |
|
| 2933599550 |
|
|
|
| USP-1269185 |
Famciclovir Related Compound B (20 mg) [4-(2-Amino-9H-purin-9-yl)-2-(hydroxymethyl)butyl acetate] |
104227-88-5 |
|
| 2933599550 |
|
|
|
| USP-1269196 |
Famciclovir Related Compound C (20 mg) (4-(2-amino-9H-purin-9-yl)-2-methylbutyl acetate) |
174155-70-5 |
|
| 2933599550 |
|
|
|
| USP-1269200 |
Famotidine (125 mg) |
76824-35-6 |
|
| 2935904000 |
|
|
|
| USP-1269221 |
Famotidine Related Compound B (25 mg) (3,5-Bis[2-[[2-[(diaminomethylene)amino]thiazol-4-yl]methylthio]ethyl]-4H-1,2,4,6-thiatriazine 1,1-dioxide) |
89268-62-2 |
|
| 2934990005 |
|
|
|
| USP-1286413 |
Frovatriptan Succinate (200 mg) |
158930-17-7 |
|
| 2933995500 |
|
|
|
| USP-1286424 |
Frovatriptan Related Compound A (20 mg) ((R)-3-Amino-2,3,4,9-tetrahydro-1H-carbazole-6-carboxamide) |
N/A |
|
| 2933997500 |
|
|
|
| USP-1286504 |
Fructose (125 mg) |
57-48-7 |
|
| 1702500000 |
|
|
|
| USP-1286606 |
L-Fucose (200 mg) |
2438-80-4 |
|
| 2940006000 |
|
|
|
| USP-1286650 |
Fulvestrant (200 mg) |
129453-61-8 |
|
| 2937230000 |
|
|
|
| USP-1286661 |
Fulvestrant System Suitability Mixture (30 mg) |
N/A |
|
| 2937230000 |
|
|
|
| USP-1295516 |
Glyburide Related Compound A (25 mg) (4-[2-(5-chloro-2-methoxybenzamido)ethyl]benzenesulfonamide) |
16673-34-0 |
|
| 2935909550 |
|
|
|
| USP-1295527 |
Glyburide Related Compound B (25 mg) (methyl-[[4-[2-[(5-chloro-2-methoxybenzoyl)-amino]ethyl]phenyl]sulfonyl]carbamate) (AS) |
21165-77-5 |
|
| 2935909550 |
|
|
|
| USP-1295662 |
beta-Glycerylphosphorylcholine (25 mg) |
18418-25-2 |
|
| 2923100000 |
|
|
|
| USP-1295709 |
Glyceryl Dibehenate (200 mg) (Glyceryl dibehenate) |
N/A |
|
| 2915900000 |
|
|
|
| USP-1295724 |
Glyceryl Distearate (500 mg) |
1323-83-7 |
|
| 2915700100 |
|
|
|
| USP-1295742 |
Glyceryl Monooleate 90% (250 mg) |
25496-72-4 |
|
| 2916155100 |
|
|
|
| USP-1295764 |
Glyceryl Monocaprylate (300 mg) |
26402-26-6 |
|
| 2915900000 |
|
|
|
| USP-1295775 |
Glyceryl Mono and Dicaprylocaprate (300 mg) |
91744-32-0 |
|
| 3824994100 |
|
|
|
| USP-1295786 |
L-alpha-Glycerylphosphorylcholine (300 mg) |
28319-77-9 |
|
| 2923100000 |
|
|
|
| USP-1295800 |
Glycine (200 mg) |
56-40-6 |
|
| 2922498050 |
|
|
|
| USP-1295822 |
L-alpha-Glycerophosphorylethanolamine (25 mg) |
33049-08-0 |
|
| 2922199695 |
|
|
|
| USP-1295844 |
Glycitein (15 mg) |
40957-83-3 |
|
| 2932996560 |
|
|
|
| USP-1295855 |
Glycitin (15 mg) |
40246-10-4 |
|
| 2938900000 |
|
|
|
| USP-1295866 |
Glycyl-L-Glutamine (200 mg) |
211446-46-7 |
|
| 2924190002 |
|
|
|
| USP-1295877 |
Glycyl-L-Tyrosine (200 mg) |
39630-46-1 |
|
| 2924296000 |
|
|
|
| USP-1295888 |
Glycyrrhizic Acid (25 mg) |
1405-86-3 |
|
| 2938900000 |
|
|
|
| USP-1296009 |
Glycopyrrolate (200 mg) |
51186-83-5 |
|
| 2933997500 |
|
|
|
| USP-1350002 |
Isopropamide Iodide (200 mg) |
71-81-8 |
|
| 2924296000 |
|
|
|
| USP-1351005 |
Isoproterenol Hydrochloride (125 mg) |
51-30-9 |
|
| 2922504500 |
|
|
|
| USP-1356869 |
Lamivudine Resolution Mixture C (0.8 mg) |
N/A |
|
| 3822190000 |
|
|
|
| USP-1356871 |
Hydrogenated Lanolin (200 mg) |
N/A |
|
| 1505009000 |
|
|
|
| USP-1356891 |
Lauryl Alcohol (125 mg) |
112-53-8 |
UN3077 |
| USP-1356916 |
Lansoprazole (150 mg) |
103577-45-3 |
|
| 2933399095 |
|
|
|
| USP-1356927 |
Lansoprazole Related Compound A (25 mg) (2-({[3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methyl}sulfonyl)benzimidazole) |
131926-99-3 |
|
| 2933399095 |
|
|
|
| USP-1356931 |
Lansoprazole Related Compound B (25 mg) (2-[[[3-Methyl-4-(2,2,2-trifluoroethoxy)-pyridin-2-yl]methyl]sulfanyl]-1H-benzimidazole monohydrate) |
1288338-69-1 |
|
| 2933399095 |
|
|
|
| USP-1356945 |
Lauroyl Arginine (100 mg) (dodecanoylarginine hydrochloride) |
N/A |
|
| 2933194350 |
|
|
|
| USP-1356949 |
Lauric Acid (500 mg) |
143-07-7 |
|
| 2915900000 |
|
|
|
| USP-1356950 |
Lauroyl Polyoxylglycerides 1500 (500 mg) |
121548-04-7 |
|
| 3824994100 |
|
|
|
| USP-1356960 |
Leflunomide (200 mg) |
75706-12-6 |
UN2811 |
| USP-1356971 |
Letrozole (200 mg) |
112809-51-5 |
|
| 2933997500 |
|
|
|
| USP-1356982 |
Letrozole Related Compound A (25 mg) (4,4′-(1H-1,3,4-triazol-1-ylmethylene)dibenzonitrile) |
112809-52-6 |
|
| 2933998350 |
|
|
|
| USP-1357001 |
L-Leucine (200 mg) |
61-90-5 |
|
| 2922498050 |
|
|
|
| USP-1357056 |
Leflunomide Related Compound B (20 mg) (Z)-2-cyano-3-hydroxy-N-(4-(trifluoromethyl)phenyl)but-2-enamide |
163451-81-8 |
UN2811 |
| USP-1357067 |
Leflunomide Related Compound C (10 mg) (N-(3′-Trifluoromethylphenyl)-5-methylisoxazole-4-carboxamide) |
61643-23-0 |
|
| 2934990005 |
|
|
|
| USP-1357125 |
Lacosamide Related Compound B (30 mg) (2-Acetamido-3-(benzylamino)-3-oxopropyl acetate) |
1822463-67-1 |
|
| 2924296000 |
|
|
|
| USP-1357158 |
Lacosamide S-Enantiomer (30 mg) ((S)-2-(Acetylamino)-N-benzyl-3-methoxypropanamide) |
175481-37-5 |
|
| 2924296000 |
|
|
|
| USP-1357170 |
Lacosamide Related Compound F (30 mg) (2-Acetamido-N-benzyl-3-hydroxypropanamide) |
171623-02-2 |
|
| 2924296000 |
|
|
|
| USP-1357475 |
Latanoprost (50 mg) |
130209-82-4 |
|
| 2937500000 |
|
|
|
| USP-1357486 |
Latanoprost Related Compound A (50 mg) (Isopropyl (E)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(3R)-3-hydroxy-5-phenylpentyl]cyclopentyl]-5-heptenoate) |
913258-34-1 |
|
| 2937500000 |
|
|
|
| USP-1357497 |
Latanoprost Related Compound B (25 mg) (Isopropyl (Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(3S)-3-hydroxy-5-phenylpentyl]cyclopentyl]-5-heptenoate) |
145773-22-4 |
|
| 2937500000 |
|
|
|
| USP-1357533 |
Latanoprost Related Compound E (25 mg) ((Z)-7-{(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(3R)-3-hydroxy-5-phenylpentyl]cyclopentyl}-5-heptenoic acid) |
41639-83-2 |
|
| 2937500000 |
|
|
|
| USP-1358004 |
Leucovorin Calcium (500 mg) |
1492-18-8 |
|
| 2936299055 |
|
|
|
| USP-1358784 |
Levalbuterol Hydrochloride (200 mg) |
50293-90-8 |
|
| 2922504500 |
|
|
|
| USP-1358795 |
Levalbuterol Related Compound A (30 mg) (4-(2-tert-Butylamino-ethyl)-2-hydroxymethyl-phenol) |
1823256-56-9 |
|
| 2922504500 |
|
|
|
| USP-1358809 |
Levalbuterol Related Compound B (20 mg) (alpha-[{(1,1-Dimethylethyl)amino}methyl]-4-hydroxy-3-methyl-benzenemethanol) |
18910-68-4 |
|
| 2922504500 |
|
|
|
| USP-1358810 |
Levalbuterol Related Compound C (30 mg) (alpha-[{(1,1-Dimethylethyl)amino}methyl]-4-hydroxy-3-(methoxymethyl)-benzenemethanol) |
18910-70-8 |
|
| 2922504500 |
|
|
|
| USP-1358820 |
Levalbuterol Related Compound D (30 mg) (5-[2-(tert-Butylamino)-1-hydroxyethyl]-2-hydroxybenzaldehyde sulfate (2:1) (salt)) |
156339-88-7 (Free base) |
|
| 2922504500 |
|
|
|
| USP-1358831 |
Levalbuterol Related Compound E (30 mg) (alpha-[{(1,1-Dimethylethyl)amino}methyl]-3-(ethoxy-methyl)-4-hydroxy-benzenemethanol) |
754926-25-5 |
|
| 2922504500 |
|
|
|
| USP-1358842 |
Levalbuterol Related Compound F (30 mg) ((R)-1-[4-(Benzyloxy)-3-(hydroxymethyl)phenyl]-2-(tert-butylamino)ethan-1-ol) |
174607-68-2 |
|
| 2922504500 |
|
|
|
| USP-1358864 |
Levalbuterol Related Compound H (10 mg) (4-[2-(tert-Butylamino)-1-methoxyethyl]-2-(hydroxymethyl)phenol acetate) |
N/A |
|
| 2922504500 |
|
|
|
| USP-1359302 |
Levamisole Hydrochloride (125 mg) |
16595-80-5 |
UN2811 |
| USP-1359404 |
Levetiracetam (200 mg) |
102767-28-2 |
|
| 2933790002 |
|
|
|
| USP-1076159 |
Bosentan Related Compound D (15 mg) (4,6-dichloro-5-(2-methoxyphenoxy)-2,2′-bipyrimidine) |
150728-13-5 |
|
| 2935909550 |
|
|
|
| USP-1076160 |
Bosentan Related Compound E (15 mg) (4-(tert-butyl)benzenesulfonamide) |
6292-59-7 |
|
| 2935909550 |
|
|
|
| USP-1076206 |
Powdered Black Cohosh Extract (1.5 g) |
84776-26-1 |
|
| 1302190200 |
|
|
|
| USP-1076250 |
Boswellia Serrata Extract (1 g) |
N/A |
|
| 1302190200 |
|
|
|
| USP-1076261 |
3-Acetyl-11-Keto-Beta-Boswellic Acid (20 mg) |
67416-61-9 |
|
| 2918300000 |
|
|
|
| USP-1076308 |
Bleomycin Sulfate (15 mg) |
9041-93-4 |
|
| 2941906000 |
|
|
|
| USP-1076329 |
Brilliant Black PN (50 mg) |
2519-30-4 |
|
| 3204196100 |
|
|
|
| USP-1076341 |
Boric Acid (1 g) |
10043-35-3 |
|
| 2810000000 |
|
|
|
| USP-1076352 |
Bretylium Tosylate (200 mg) |
61-75-6 |
|
| 2923900100 |
|
|
|
| USP-1096270 |
Carbomer Copolymer (100 mg) |
138789-85-2 |
|
| 3906906000 |
|
|
|
| USP-1096281 |
Carbomer Homopolymer (100 mg) |
151687-96-6 |
|
| 3906906000 |
|
|
|
| USP-1096407 |
Carboplatin (100 mg) |
41575-94-4 |
|
| 2843900000 |
|
|
|
| USP-1096510 |
Carglumic Acid Related Compound A (30 mg) ((S)-3-(2,5-dioxoimidazolidin-4-yl)propanoic acid) |
17027-50-8 |
|
| 2933290000 |
|
|
|
